The Gross Margin of BrightGene Bio-Medical Technology Co Ltd (688166.SS) is 56.30%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 56.30% |
| 2023-12-31 | 53.97% |
| 2022-12-31 | 61.57% |
| 2021-12-31 | 55.33% |
| 2020-12-31 | 53.73% |
| 2019-12-31 | 62.78% |
| 2018-12-31 | 58.40% |
| 2017-12-31 | 58.78% |
| 2016-12-31 | 57.54% |